BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 18723249)

  • 1. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.
    Garey KW; Dao-Tran TK; Jiang ZD; Price MP; Gentry LO; Dupont HL
    J Hosp Infect; 2008 Oct; 70(2):142-7. PubMed ID: 18723249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection.
    Hu MY; Katchar K; Kyne L; Maroo S; Tummala S; Dreisbach V; Xu H; Leffler DA; Kelly CP
    Gastroenterology; 2009 Apr; 136(4):1206-14. PubMed ID: 19162027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case-control study of community-associated Clostridium difficile infection.
    Wilcox MH; Mooney L; Bendall R; Settle CD; Fawley WN
    J Antimicrob Chemother; 2008 Aug; 62(2):388-96. PubMed ID: 18434341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain.
    Carignan A; Allard C; Pépin J; Cossette B; Nault V; Valiquette L
    Clin Infect Dis; 2008 Jun; 46(12):1838-43. PubMed ID: 18462108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors.
    Debast SB; Vaessen N; Choudry A; Wiegers-Ligtvoet EA; van den Berg RJ; Kuijper EJ
    Clin Microbiol Infect; 2009 May; 15(5):427-34. PubMed ID: 19416295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and risk factors for Clostridium difficile infection in children.
    Sandora TJ; Fung M; Flaherty K; Helsing L; Scanlon P; Potter-Bynoe G; Gidengil CA; Lee GM
    Pediatr Infect Dis J; 2011 Jul; 30(7):580-4. PubMed ID: 21233782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile in cardiac surgery: risk factors and impact on postoperative outcome.
    Crabtree T; Aitchison D; Meyers BF; Tymkew H; Smith JR; Guthrie TJ; Munfakh N; Moon MR; Pasque MK; Lawton J; Moazami N; Damiano RJ
    Ann Thorac Surg; 2007 Apr; 83(4):1396-402. PubMed ID: 17383346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile-associated disease and mortality among the elderly critically ill.
    Zilberberg MD; Shorr AF; Micek ST; Doherty JA; Kollef MH
    Crit Care Med; 2009 Sep; 37(9):2583-9. PubMed ID: 19623053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection.
    Stevens V; Dumyati G; Fine LS; Fisher SG; van Wijngaarden E
    Clin Infect Dis; 2011 Jul; 53(1):42-8. PubMed ID: 21653301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients.
    Chopra T; Alangaden GJ; Chandrasekar P
    Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1113-9. PubMed ID: 20954878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C. difficile infection (CDI) in a long-term acute care facility (LTAC).
    Goldstein EJ; Polonsky J; Touzani M; Citron DM
    Anaerobe; 2009 Dec; 15(6):241-3. PubMed ID: 19683064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options.
    Lo Vecchio A; Zacur GM
    Curr Opin Gastroenterol; 2012 Jan; 28(1):1-9. PubMed ID: 22134217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series.
    Fowler S; Webber A; Cooper BS; Phimister A; Price K; Carter Y; Kibbler CC; Simpson AJ; Stone SP
    J Antimicrob Chemother; 2007 May; 59(5):990-5. PubMed ID: 17387117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting.
    Dalton BR; Lye-Maccannell T; Henderson EA; Maccannell DR; Louie TJ
    Aliment Pharmacol Ther; 2009 Mar; 29(6):626-34. PubMed ID: 19183143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].
    Tunçcan OG; Ulutan F; Karakuş R
    Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.
    McFarland LV; Clarridge JE; Beneda HW; Raugi GJ
    Clin Infect Dis; 2007 Nov; 45(9):1141-51. PubMed ID: 17918075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of critical care unit utilization and mortality in patients infected with Clostridium difficile.
    Gasperino J; Garala M; Cohen HW; Kvetan V; Currie B
    J Crit Care; 2010 Jun; 25(2):282-6. PubMed ID: 19592210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
    King RN; Lager SL
    Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated system to identify Clostridium difficile infection among hospitalised patients.
    Yadav Y; Garey KW; Dao-Tran TK; Kaila V; Gbito KY; DuPont HL
    J Hosp Infect; 2009 Aug; 72(4):337-41. PubMed ID: 19596490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in laboratory and clinical workload for Clostridium difficile infection from 2003 to 2007 in hospitals in Edinburgh.
    Reddy S; Taori S; Poxton IR
    Clin Microbiol Infect; 2010 Apr; 16(4):340-6. PubMed ID: 20222891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.